Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials
Conclusions
In this case study, journal publications provided insufficient information on harms outcomes of clinical trials and did not specify that a subset of harms data were being presented. Clinical study reports often present data on harms, including serious adverse events, which are not reported or mentioned in the journal publications. Therefore, clinical study reports could support a more complete, accurate, and reliable investigation, and researchers undertaking evidence synthesis of harm outcomes should not rely only on incomplete published data that are presented in the journal publications. (Source: Trials)
Source: Trials - April 21, 2016 Category: Research Source Type: clinical trials
Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults
Condition: ObesityIntervention: Drug: OrlistatSponsor: Hoffmann-La RocheCompleted - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2016 Category: Research Source Type: clinical trials
